Study Designed to Optimize the Treatment of Primary Pneumothorax

• Status: Recruiting
• Trial end date: 2024-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Knowledge about incidence, risk factors and genetic predispositions of primary spontaneous pneumothorax in young adults is very limited, and treatment has also been controversial.The Aim of this study is to optimize the treatment, estimate the actual incidence, and identify possible risk factors including genetic predispositions.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Odense University Hospital
• Collaborators: Danish Medical Association; Danmarks Lungeforening

Criteria

Inclusion Criteria:

• First incidence of primary spontaneous pneumothorax.

• Age between 18 and 40.

• No known preexisting pulmonary disease.

• Patient must accept randomization.

• Able to read and understand information regarding the study.

• The condition must require treatment with a chest-tube.

Exclusion Criteria:

• Age above 40.

• Previously pulmonary og cardiac surgery.

• Pregnant or breastfeeding.

• Patients who do not tolerate anesthetics.